Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients.
Maryland Attorney General Brian Frosh announced that he had filed administrative charges against Arizona-based Insys, which he said provided thousands of dollars in inducements to doctors to promote prescribing its medication Subsys to their patients.
The company declined comment. It has said that it has taken steps to prevent past mistakes from happening again.
Maryland alleged the company influenced doctors to prescribe the drug beyond its labeled use with inducements that included payments purported to be compensation for participating in educational events.
Capital Gazette Op Ed – Brian Frosh: State has taken steps to curb gun violence; Congress needs to do more
The horror and uncertainty we feel in the wake of the attack in the Capital Gazette newsroom has gripped our state, and, like all Marylanders, I share in the grief. Words of elected leaders will [...]
Maryland plans to take the Trump administration to federal appeals court now that the Environmental Protection Agency has rejected the state's demands that it do more to limit coal power plant emissions in upwind states. [...]
Maryland Attorney General Brian E. Frosh today joined 55 other state and territory attorneys general in urging Congress to reauthorize the Violence Against Women Act (VAWA) before it expires this year. “Thousands of victims of [...]